Delivery Order SPE2DB24D2105-SPE2DB25FAPZY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $5,028.35. This competitively awarded, firm fixed-price delivery order is set to conclude by September 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Valtoco 15 mg nasal spray, a medication used for acute seizure management. This firm fixed-price delivery order, valued at $3,385.62, represents a non-competitive set-aside contract and is scheduled for completion by July 24, 2025. The award was issued from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Valtoco 15 mg nasal sprays, valued at $3,771.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to be completed by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,543.14. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 10 mg nasal sprays with a ceiling value of $1,441.57. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child delivery order under a larger contract vehicle....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order represents a non-set-aside competitive award performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract is scheduled for completion by September 4, 2025, indicating a rapid fulfillment timeline typical of urgent medical supply needs within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for Valtoco 10 mg nasal sprays, with a ceiling value of $1,140.52 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of June 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAPZYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen regularly supplies critical medications and medical commodities to federal military and veteran healthcare systems through the Defense Logistics Agency. Valtoco is a seizure rescue medication delivered via nasal spray, representing the type of specialized pharmaceutical product that falls within the company's extensive portfolio of brand-name and generic drugs supplied to support military healthcare programs worldwide. The rapid completion timeline reflects the urgent nature of this small-value medical supply delivery to support Defense Health Agency and other federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/4/25 |